The efficacy and safety of exenatide once weekly in patients with type 2 diabetes

Sebastian M. Heimburger; Andreas Bronden; Nicklas J. Johansen; Thomas F. Dejgaard; Tina Vilsboll; Filip K. Knop

doi:10.1080/14656566.2019.1571040

The efficacy and safety of exenatide once weekly in patients with type 2 diabetes

Sebastian M. Heimburger, Andreas Bronden, Nicklas J. Johansen, Thomas F. Dejgaard, Tina Vilsboll, Filip K. Knop

Institut for Klinisk Medicin

6 Citationer (Scopus)

Originalsprog	Engelsk
Tidsskrift	Expert Opinion on Pharmacotherapy
Vol/bind	20
Udgave nummer	5
Sider (fra-til)	501-510
Antal sider	11
ISSN	1465-6566
DOI	https://doi.org/10.1080/14656566.2019.1571040
Status	Udgivet - 24 mar. 2019

FN’s Verdensmål

Dette resultat bidrager til følgende verdensmål

Adgang til dokumentet

10.1080/14656566.2019.1571040

Citationsformater

@article{ddfe9fd873704f1fa3dc60199ecbf622,

title = "The efficacy and safety of exenatide once weekly in patients with type 2 diabetes",

keywords = "Exenatide extended-release, exenatide QW, glucagon-like peptide 1, glucagon-like peptide 1 receptor agonist, glycaemic control, type 2 diabetes, cardiovascular adverse events",

author = "Heimburger, {Sebastian M.} and Andreas Bronden and Johansen, {Nicklas J.} and Dejgaard, {Thomas F.} and Tina Vilsboll and Knop, {Filip K.}",

year = "2019",

month = mar,

day = "24",

doi = "10.1080/14656566.2019.1571040",

language = "English",

volume = "20",

pages = "501--510",

journal = "Expert Opinion on Pharmacotherapy",

issn = "1465-6566",

publisher = "Taylor & Francis",

number = "5",

}

TY - JOUR

T1 - The efficacy and safety of exenatide once weekly in patients with type 2 diabetes

AU - Heimburger, Sebastian M.

AU - Bronden, Andreas

AU - Johansen, Nicklas J.

AU - Dejgaard, Thomas F.

AU - Vilsboll, Tina

AU - Knop, Filip K.

PY - 2019/3/24

Y1 - 2019/3/24

KW - Exenatide extended-release

KW - exenatide QW

KW - glucagon-like peptide 1

KW - glucagon-like peptide 1 receptor agonist

KW - glycaemic control

KW - type 2 diabetes

KW - cardiovascular adverse events

U2 - 10.1080/14656566.2019.1571040

DO - 10.1080/14656566.2019.1571040

M3 - Journal article

C2 - 30730773

SN - 1465-6566

VL - 20

SP - 501

EP - 510

JO - Expert Opinion on Pharmacotherapy

JF - Expert Opinion on Pharmacotherapy

IS - 5

ER -

The efficacy and safety of exenatide once weekly in patients with type 2 diabetes

FN’s Verdensmål

Adgang til dokumentet

Fingeraftryk

Citationsformater